Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to learn which is better, combining Dexmedetomidine infusion and paragastric neural block or combining laparoscopic TAP block and paragastric neural block to enhance recovery after laparoscopic sleeve gastrectomy. The main questions it aims to answer are: Will using paragastric neural block (PGNB) combined with dexmedetomidine infusion give better recovery or using PGNB combined with laparoscopic transversus abdominis plane (LTAP) block in patients undergoing laparoscopic sleeve gastrectomy. This will be assessed by: Recording how much opioids were consumed by the patients Hemodynamic stability of the enrolled patients Pain scores as given by the patient The quality of postoperative patient recovery How many patients encountered nausea or vomiting
Age
20 - 60 years
Sex
ALL
Healthy Volunteers
No
Alexandria Main University Hospital
Alexandria, Egypt
Start Date
April 3, 2025
Primary Completion Date
June 4, 2025
Completion Date
June 20, 2025
Last Updated
May 14, 2025
60
ESTIMATED participants
Dexmedetomidine infusion
DRUG
Paragastric neural block
PROCEDURE
Laparoscopic Transversus Abdominis Plane (LTAP) block
PROCEDURE
Lead Sponsor
Alexandria University
NCT06515691
NCT07274215
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions